EVENTS
Join AustinPx at an upcoming industry event. Schedule a meeting with us by clicking the links for each event, below.
Upcoming Events
PBSS: Pharmacokinetics in Drug Discovery and Development: Fundamentals, Applications and Case Studies
October 9th, 2025 at Crowne Plaza Hotel, Foster City, CA
AustinPx Live: From Brick Dust to Breakthrough: The Power of Enabled Formulation
October 22nd, 2025 | 11am CT / 12pm EDT
Join us for our fourth episode of AustinPx Live where Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx uses enabling formulation strategies to advance molecules once considered too complex to develop. He’ll highlight how our expertise with KinetiSol™, polymer and excipient screening, and biopharm-guided design-of-experiments creates formulations that achieve exposure, maintain stability, and are built for real-world manufacturability. This 30-minute session includes a 20-minute presentation followed by live Q&A.
CPhI Frankfurt 2025
October 28-30, 2025 at Messe Frankfurt, Frankfurt, Germany
Celebrating 35 years of uniting pharma, CPHI Frankfurt 2025 will gather industry leaders, innovators, and experts from around the world. Explore the latest advancements, cutting-edge technologies, and transformative trends shaping the future of pharmaceuticals. With dynamic exhibitions, networking opportunities, and expert-led sessions, this event offers a platform to connect, collaborate, and drive industry progress. AustinPx Chief Executive Officer Elizabeth Hickman will be in attendance.
2025 AIChE Annual Meeting
November 2-6, 2025 at John B. Hynes Memorial Convention Center, Marriott Copley Place, Sheraton Boston, Boston, MA
The 2025 AIChE® Annual Meeting unites academic and industry researchers at all career stages seeking innovation and professional development. Connect with a diverse audience to gain insights on the latest research, network with experts, and advance your career. AustinPx Sr. Vice President, Operations Justin Keene, PhD and Executive Director Rob Rigney will be in attendance.
The Biotech BREWDOWN Happy Hour with AustinPx
RSVP for The Biotech BREWDOWN Happy Hour from 4:30–7:30 PM on Wednesday, November 5th in Boston, MA
Join AustinPx during our next happy hour, The Biotech BREWDOWN in Boston, MA. It's your chance to mix with the pharmaceutical and biotech community over good brews, good conversation, and plenty of new ideas, all on our tab.
Come ready to spark collaborations, reconnect with colleagues, or just enjoy a well-earned night out. This happy hour blends the best of networking and socializing into one memorable evening.
The event will be held on Wednesday, November 5th from 4:30–7:30 PM at:
Back Bay Social
867 Boylston St Boston MA
4:30–7:30 PM
WEBINAR: Converting Spray Drying to KinetiSol™:
Solving Late- Stage Formulations & Manufacturing Challenges
Xtalks Webinar: November 6, 2025, 11:00 AM EDT, 60 minutes
With Dave Miller, AustinPx CSO. Spray drying is a well-established and widely accepted approach. However, the formulation and manufacturing limitations of spray drying are equally well known. This webinar will demonstrate how converting SDDs to KinetiSol enables higher-performing formulations, more efficient tablet manufacturing, and solvent-free processing that improves scalability, quality, and patient outcomes for late-stage clinical development and beyond.
Good Laboratory Practices (GLPs) and Good Manufacturing Practices (GMPs) in Drug Development: Fundamentals, Regulatory Trends and Best Practices
November 6th, 2025 at the Hilton Garden Inn, San Mateo, CA
This workshop will be conducted in two sessions: "Good Laboratory Practices (GLPs): Fundamentals, Regulatory Trends and Best Practices" and "Good Manufacturing Practices (GMPs) from R&D through Commercialization: Fundamentals, Regulatory Trends and Best Practices." AustinPx CSO Dave Miller and Director of Business Development Danny Davis will be in attendance.
AAPS 2025 PHARMSCI 360
November 9-12, 2025 at the Henry B. Gonzalez Convention Center, San Antonio, TX
AAPS brings together pharmaceutical scientists from around the world to share research and exchange ideas in order to improve global health. PharmSci 360 is an important part of this work, drawing thousands of scientists to the largest, richest scientific conversation of the year. AustinPx CSO Dave Miller and Director of Business Development Danny Davis will be in attendance.
Past Events (2025)
September 25th, 2025 | 11am CT / 12pm EDT
Join us for the third session in our AustinPx Live series! Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx approaches conventional formulation to accelerate First-in-Human studies without sacrificing scientific rigor. He’ll highlight how our expertise in powder-in-capsule dosing, phase-appropriate analytical support, and early manufacturability considerations helps sponsors navigate tight timelines and reach the clinic with confidence. This 30-minute session includes a 20-minute presentation followed by live Q&A.
September 15-16, 2025 at The Westin Copley Place, Boston, Massachusetts
The 15th American Drug Delivery & Formulation will once again bring together an exceptional line-up of the industry's best speakers, with technical experts, industry leaders, and specialists providing an unmissable two days of the latest information. Now in its 15th year, the summit continues to go from strength to strength. Last year saw a record number of attendees with over 300 scientific leaders from pharma, biotech, and drug delivery industries. AustinPx Executive Director Rob Rigney will be in attendance.
Wednesday, September 17th, 4:00—6:30 p.m. at The Dinky Bar & Kitchen, Princeton, NJ
Join AustinPx at out next happy hour, Shaken, Stirred, and Science-Fueled, in Princeton, NJ. It's your chance to mix with the pharmaceutical and biotech community over good drinks, good conversation, and plenty of new ideas, all on our tab. We look forward to seeing you there
The event will be held on Wednesday, September 17th from 4:00–6:30 PM at:
The Dinky Bar & Kitchen
94 University Place Princeton, NJ
4:00–6:30 PM
September 18-19, 2025 at the Hyatt Regency, New Brunswick, New Jersey
Visit AustinPx at Booth 68
The 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition will be held September 18-19, 2025 at the Hyatt Regency New Brunswick, NJ, located in the heart of New Jersey’s pharmaceutical industry. The two-day conference and one-day exhibition on September 18th provides the perfect venue for easy, informal discussions for manufacturing, packaging, lab services and more! The tabletop exhibition will be held one day only on Thursday, September 18th with an additional half day of sessions held on Friday, September 19th. AustinPx Executive Director Rob Rigney will be in attendance.
BioCom California Bay Area
August 27th, 2025 at Biocom California Bay Area, PAC Conference Center, South San Francisco, CA
AustinPx’s Director of Business Development Danny Davis will present on how a majority of today’s new drug candidates suffer from poor water solubility, limiting their absorption and potentially compromising therapeutic outcomes. In this presentation, we will explore how formulation-based solubility enhancement strategies can transform the development and clinical success of these compounds.
Join us at Biocom California for a fast-paced and insight-packed session exploring how the life sciences industry is navigating regulatory change, accelerating innovation, and preparing for the future of drug development.
August 19th, 2025 | 11am CT / 12pm EDT
Join us for the next session in our AustinPx Live series! Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx designs data-driven, early-phase strategies to solve complex drug development challenges. He’ll highlight our tailored analytical services, preclinical expertise, and how they connect with our broader CDMO model. This 30-minute session includes a 20-minute presentation followed by live Q&A.
August 7th, 2025 | 11am EDT / 4pm BST / 5pm CEST | Virtual
AustinPx’s Chief Scientific Officer, Dave Miller, and Dr. Zachary Warnken of Via Therapeutics will co-present a live Xtalks webinar on formulation strategies for pediatric oral drug products. Pediatric dosage forms must address factors like swallowing ability, taste, and dosing flexibility while overcoming solubility, palatability, and manufacturability challenges.
Through a real-world case study, attendees will learn how high-drug load mini-tablets were developed for low-resource settings using compaction simulation, powder rheometry, and functional coatings. This session offers practical insights for creating dosage forms that are effective, scalable, and suitable for pediatric patients.
July 9th, 2025 | 11am CT / 12pm EDT
Join us as we kick off our new AustinPx Live series with an inside look at our capabilities. AustinPx's Chief Scientific Officer, Dave Miller, will walk through who we are, what we do, and how our integrated CDMO services and KinetiSol technology are helping partners overcome complex drug development challenges. This 30-minute session includes a 20-minute presentation followed by live Q&A.
June 22-27, 2025 at the University of Southern Maine, Portland, Maine
Preclinical Form and Formulation for Drug Discovery:
Using Big and Small Data to Bridge the Gap in Pharmaceutical Design and Clinical Translation
The Preclinical Form and Formulation for Drug Discovery GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. AustinPx CSO Dave Miller will be in attendance.
June 16, 2025 at the
Analytical Development & Quality Control in Small Molecule Drug Development
This PBSS workshop provides a deep dive into the essential analytical techniques, regulatory compliance, and strategic quality control approaches required throughout the drug development lifecycle. Participants will gain insights into the characterization of drug substances and drug products, impurity profiling, stability studies, and cutting-edge control strategies for mutagenic impurities, including nitrosamines. AustinPx Director of Business Development Danny Davis and Senior Director of Business Development Collin Burger will be in attendance.
June 16-19, 2025 at the Boston Convention & Exhibition Center, Boston, Massachusetts
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. AustinPx Chief Executive Officer Elizabeth Hickman and Executive Director Rob Rigney will be in attendance.
June 12, 2025 at the
Human PK and Dose Projection for Small Molecules: Fundamentals, Applications and Case Studies
This PBSS workshop will cover strategies, best practices, and regulatory guidance for toxicological assessments to assess workplace safety, product quality / patient safety, and environmental toxicology. Included will be a discussion on occupational safety, toxicological risk assessment, impurities, cleaning validation, and will cover different modalities such as biologics or small molecules. AustinPx Senior Director of Business Development Collin Burger will be in attendance.
Tuesday, June 10th, 4-7 p.m. at Foundry & Lux, South San Francisco, California
Hosted by AustinPx during the Compact Simulation Forum in South San Francisco, CA. Appetizers and drinks are on us during our Sip, Simulate & (De)compress. RSVP via the form below. We look forward to seeing you there!
Foundry & Lux
151 Oyster Point Blvd, South San Francisco, CA 94080
June 9-11, 2025 at Genentech HQ, San Francisco, California
The Compact Simulation Forum an immersive workshop designed for pharmaceutical scientists, engineers, and regulatory professionals seeking to deepen their understanding of compaction simulation and its pivotal role in regulatory submissions. AustinPx CSO Dave Miller's presentation, Development of a High-Drug Load, Functionally Coated Pediatric Mini-Tablet Formulation Using the STYL’One Nano Compaction Simulator, is an event highlight you won't want to miss!
Wednesday, May 14th, 5:30-8:30PM at The Lexington at Cambridge Crossing, Cambridge MA
Hosted by AustinPx during the Fiber Optic Training Forum in Woburn, MA. Appetizers and drinks are on us during our A Night Out with Friends Happy Hour with AustinPx Director of Business Development Danny Davis, PhD. RSVP via the form below. We look forward to seeing you there!
The Lexington at Cambridge Crossing
Roof Deck & Bar
100 N. First St., Cambridge MA 02141
April 30, 2025 | 11am EDT / 4pm BST / 5pm CEST | Virtual
AustinPx’s Chief Scientific Officer, Dave Miller, will present a live Xtalks webinar focused on how to reduce pill burden without compromising bioavailability in amorphous solid dispersions (ASDs). Attendees will gain insights into the tradeoffs involved in drug loading and polymer selection, supported by real-world case studies and practical formulation strategies.
This presentation will challenge common assumptions in ASD design. Dave will explain why increasing drug content does not always lead to better performance and will explore how formulation decisions affect morphology, supersaturation, and drug absorption.
April 14-17, 2025 at the Hilton Bayfront, San Diego, California
Drug Discovery Chemistry is a dynamic conference for medicinal, biophysical, and computational chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule and macrocyclic drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's interests by going back and forth among concurrent tracks. AustinPx CSO Dave Miller and Sr. Director, Business Development Collin Burger will be in attendance.
Monday, April 14, 2025 from 4:30-7PM at Gravity Heights, Sorrento Valley
Hosted by AustinPx during Drug Discovery Chemistry in San Diego, CA. Appetizers and craft brews are on us during our Appetizers & ASDs Happy Hour with AustinPx CSO, Dave Miller. RSVP via the link below. We look forward to seeing you there! Gravity Heights, 9920 Pacific Heights Blvd., San Diego, CA 92121
April 10, 2025 at Purdue University, West Lafayette, Indiana
Shaping the Future of Pharmaceuticals: The Evolving Definition of an API. Co-processing has significant potential to improve pharmaceutical manufacturing and streamline development by allowing co-processed drug substance (API) to be manufactured in one step. The 2025 Peck Symposium will explore this changing concept of what an API is. AustinPx CSO Dave Miller and Executive Director Rob Rigney will be in attendance.
April 11, 2025 in Groton, Connecticut
The AAPS Northeast Regional Discussion Group Annual Meeting is a premier scientific event that will bring together leading experts from academia, the pharmaceutical industry, and regulatory authorities. Mark your calendars for this exciting opportunity to engage with brilliant minds and explore the latest innovations in the field! AustinPx is a Silver Sponsor of the the 2025 NERDG Discussion Group.
April 1-3, 2025 at Javits Center in New York City
AustinPx will be showcasing The KinetiSol™ Technology equipment at this year’s Interphex. Elizabeth Hickman, CBO, Dave Miller, CSO, Chris Brough, CTO, Collin Burger, Sr. Directory of Business Development, Rob Rigney, Sr. Director of Business Development, and others will be in New York for Interphex. Schedule a meeting with them to learn more about the next generation amorphous dispersion technology.
February 26-27, 2025 at AustinPx, Georgetown, TX
AustinPx will be hosting an industry workshop February 26-27, 2025 on downstream aspects of amorphous solid dispersions. This two-day workshop will consist of a facility tour, authentic Austin BBQ, presentations by industry experts, a night out on the town.
Past Events (2024)
Wednesday, December 11th, 4:30-8:00 PM at the Liberty Hotel, Boston, MA
To celebrate the season, AustinPx is hosting a Holiday innovation soiree at The Liberty Hotel full of drinks, food, laughs, and conversation. AustinPx’s CSO, Dave Miller, PhD, will lead a discussion on how innovative formulation technologies are redefining drug-like properties and enabling the development of drugs targeting the undruggable space.
Come for the cocktails and dinner but stay for the innovation. We hope you can join us!
Wednesday, November 6th, 4-7PM at Research Triangle Park, NC
Hosted by AustinPx and Lubrizol Life Science. The suds are on us during our Suds & Solubility Happy Hour at Boxyard RTP at Research Triangle Park, NC. RSVP via the form below. We look forward to seeing you there!
Boxyard RTP
900 Park Offices Drive
Research Triangle Park, NC 27709
October 20-23, 2024 at Salt Palace Convention Center, Salt Lake City, UT
AAPS brings together pharmaceutical scientists from around the world to share research and exchange ideas in order to improve global health. PharmSci 360 is an important part of this work, drawing thousands of scientists to the largest, richest scientific conversation of the year. The importance of that scientific conversation and its ability to advance global health is why the Board of Directors has determined that AAPS will present the full PharmSci 360 program both online including the entire scientific program as well as networking events, career development opportunities, posters, and partner engagements.
Meet with AustinPx Sr. Director Business Development Collin Burger during AAPS 2024 Pharmsci 360 to learn how we can help advance your pharmaceutical product pipeline.
October 8-10, 2024 in Fiera Milano, Italy
Tuesday, October 1, 2024 | 1pm EDT (10am PDT) | 60 min
As the number of poorly soluble molecules entering the pipeline has increased, the application of amorphous solid dispersions development has grown. With the advent of next-generation ASD technologies, like KinetiSol™ Technology, drug developers are setting new standards in scalability, sustainability and performance.
In this webinar, the expert speakers will share their scale-up experiences and perspectives on opportunities to improve technology transfers for amorphous solid dispersions. They will define best practices for a successful scale-up and a more complete and efficient tech transfer for the commercialization of amorphous solid dispersions.
Speakers:
Dr. Justin Keen, PhD, Senior Vice President, Operations, AustinPx
TJ Highley, MBA, CEO and Board Member, Microsize
September 26-27, 2024 at the Hyatt Regency, New Brunswick, NJ
Located in the heart of New Jersey’s pharmaceutical industry. The two-day conference and one-day exhibition on September 26thth provides the perfect venue for easy, informal discussions for manufacturing, packaging, lab services and more! The tabletop exhibition will be held one day only on Thursday, September 26th with an additional half day of sessions held on Friday, September 27th.
September 16-17, 2024 at the Hyatt Regency La Jolla, San Diego, CA
Bringing you innovative solutions to the greatest challenges in pharmaceuticals, biologics and device development. The American Drug Delivery & Formulation will once again bring together an exceptional line-up of the industry's best speakers, with technical experts, industry leaders, and specialists providing an unmissable two days of the latest information.
AustinPx Chief Scientific Officer Dave Miller will be speaking at the American Drug Delivery & Formulation Summit. Schedule a meeting with Dave during the summit to learn more about AustinPx's drug development and manufacturing capabilities.
June 25-26 at the Hyatt Regency Princeton, Princeton NJ
Connect with 160+ senior drug development innovators in Princeton, NJ this May for industry's leading drug product development Summit. Meet with AustinPx Sr. Director of Business Development, Rob Rigney, during the summit to see how we can help advance your pharmaceutical product pipeline.
June 3-6, 2024 at the San Diego Convention Center, San Diego, CA
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe. Meet with AustinPx Business Development Director, Collin Burger, during the convention to see how we can help bring your next drug candidate to market quickly and efficiently.
CPhI North America, May 8, 2024, 6-9PM at McGillin's Olde Ale House, Philadelphia
Want to maximize your time at CPHI in Philadelphia next week? Come out on Wednesday night for a happy hour on us with 4 key players in Drug Development & Solubility problem solving space!
April 30, 2024, 8:45am - 5:30pm in San Diego, CA
In-Person Workshop: Small Molecule Preclinical Development and IND Filing: Nuts, Bolts and Best Practices. Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward.
April 16-18, 2024 in New York City
AustinPx will be showcasing The KinetiSol™ Technology equipment at this year’s Interphex. Elizabeth Hickman, CBO, Chris Brough, CTO, Rob Rigney, Sr. Director of Business Development, and Angie Hoffnagle, Marketing Director, will be in New York for Interphex. Schedule a meeting with them to learn more about the next generation amorphous dispersion technology.
April 2, 2024 at the Omni Austin Hotel Downtown
AustinPx is an exhibitor at the 2024 Texas Life Sciences Summit. The Texas Life Summit brings together state leaders, life science companies, economic development organizations, academic institutions, and service providers that support the ecosystem.
March 22, 2024 in Groton, Connecticut
The purpose of the AAPS Northeast Regional Discussion Group (NERDG) is to: Foster education in and knowledge of the pharmaceutical sciences; Provide a local forum at which all scientists interested in the advancement of the pharmaceutical sciences may meet in professional and personal fellowship; and Share the scientific interests of researchers within the northeastern United States. Early registration ends on 8th March 2024.
March 18- 21, 2024 in New York City
The speed, flexibility, and knowhow to accelerate your drug candidate’s path to the clinic or market. Elizabeth Hickman, CBO, Rob Rigney, Sr. Director of Business Development, and Angie Hoffnagle, Marketing Director, will be in New York for DCAT week. Schedule a meeting with them to discuss your CMC and product development needs at one of the conferences.
February 8, 2024, 6-9PM, Highpoint in Austin, TX
AustinPx is a proud sponsor of BioAustinCTX's BioBash on February 8, 2024. At this BioBash, the focus is on the development of Incubators in Central Texas and how they help improve and promote growth in the Life Science industry. We hope you are able to join AustinPx for a great night of learning and networking. Registration fee is just $20.
January 8 - 11, 2024 in San Francisco
From accelerated development to bioavailability enhancement, AustinPx has the tools to help unlock the full potential of your molecule. Tim Scott, CEO, Elizabeth Hickman, CBO, and Collin Burger, Sr. Director of Business Development, will be in San Francisco for JP Morgan week, including RESI and Biotech Showcase. Schedule a meeting with them to discuss your CMC and product development needs at one of the conferences.
Past Events (2023)
December 13th, 2023, 4:30-7:00pm
KinetiSol is a game-changing, commercially ready technology that is revolutionizing amorphous dispersions development and manufacturing. With its significantly smaller environmental and commercial footprint, broader formulation design space, rapid processing and easier scale up, KinetiSol is a better, faster and lower cost solution compared to spray drying. This presentation will showcase how KinetiSol has replicated and improved upon the bioavailability, manufacturability, and ecological footprint of spray dried dispersion drugs.
During the discussion, we will contrast the facility, utilities, and down stream processing requirements for KinetiSol compared to spray drying. Finally, we will dive into the biopharmaceutical performance benefits achievable with KinetiSol. These benefits will be demonstrated by a series of case studies and explained with data. By the end of the lecture, you will wonder why you ever developed your drug on a spray dryer.
The presentation, by AustinPx CSO Dave Miller, PhD will be approximately 30 minutes while guestes enjoy delectable appetizers and beverages. The presentation will be followed by a sit-down dinner.